ANNUAL REPORT FOR THE YEAR ENDED 12-31-09

Company

Raphael Pharmaceutical Inc.

Filed

April 19, 2010

Period of Report

December 31, 2009

Accession Number

0001165527-10-000304

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →